IV Contrast Material for PET/CT: Counterpoint—Critical Concerns Remain
Authors:
- 1 December 2022
- journal article
- editorial
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 219 (6) , 882-883
Abstract
This article does not include an Please see the accompanying Point by Colm B. Kelleher and Terence Z. Wong.Keywords
This publication has 5 references indexed in Scilit:
- Does intravenous contrast improve the diagnostic yield of fluorodeoxyglucose positron-emission tomography/computed tomography in patients with head-and-neck malignancyIndian Journal of Nuclear Medicine, 2020
- Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphomaNuclear Medicine Communications, 2019
- No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase18F-Fluorethylcholine PET/CT for prostate cancerJournal of Medical Imaging and Radiation Oncology, 2016
- Initial Staging of Hodgkin’s DiseaseMedicine, 2014
- Quantitative Effects of Contrast Enhanced CT Attenuation Correction on PET SUV MeasurementsMolecular Imaging and Biology, 2007